Director/PDMR Shareholding
Released : 20 June 2023 11:45
RNS Number : 3167DM&G PLC20 June 2023M&G plc NEWS RELEASE
20 June 2023
M&G plc
Notification of transaction by Person Discharging Managerial Responsibilities ('PDMR')
M&G plc announces that Benoît Macé, Chief Strategy & Transformation Officer, purchased 17,000 ordinary shares of 5 pence each on 15 June 2023.
The notification below has been made in accordance with the requirements of the Market Abuse Regulation and provides further detail.
Contact
Charlotte Heiss, General Counsel and Company Secretary - 020 8162 4064
George Bayer, Deputy Company Secretary - PLC & Governance - 020 8162 2655
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Benoît Macé |
2 |
Reason for the notification |
|
a) |
Position/status |
Chief Strategy & Transformation Officer |
b) |
Initial notification/Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
M&G plc |
b) |
LEI |
254900TWUJUQ44TQJY84 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 5 pence each
|
b) |
Nature of the transaction |
Purchase of shares |
c) |
Price(s) and volume(s) |
|
Price (s) |
Volume (s) |
|
£2.026 |
17,000 |
|
|
Aggregated information -Aggregated volume -Price |
17,000 £2.026 |
|
Date of the transaction |
2023-06-15 |
|
Place of the transaction |
XLON |
|
LEI: 254900TWUJUQ44TQJY84
Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDDSHSEMFSSEDSEFM